Get the Daily Brief
Latest Biotech News
FDA Accelerates Drug Reviews with New Priority Voucher to Tackle US Health Crises
The U.S. Food and Drug Administration has launched a pilot program offering priority review vouchers to drug developers whose products address identified national health priorities, promising to...
Eli Lilly Acquires Verve Therapeutics in $1.3 Billion Deal to Expand Cardiovascular Gene Editing
Eli Lilly & Co. agreed to acquire Verve Therapeutics for up to $1.3 billion, including upfront and milestone payments, marking a strategic investment to broaden its cardiovascular pipeline through...
Scholar Rock’s Myostatin Blocker Preserves Muscle in Weight Loss Patients Taking Zepbound
Scholar Rock Pharmaceuticals reported that its investigational myostatin-blocking antibody, apitegromab, successfully preserved lean muscle mass in patients taking Eli Lilly's obesity drug...
Advanced Single-Cell and Multi-Omic Studies Illuminate Disease Mechanisms and Biomarkers
Cutting-edge research employing single-cell RNA sequencing and multi-omics is elucidating complex disease mechanisms and identifying novel biomarkers across multiple conditions. Studies have...
Breakthrough Immunotherapies and AI Drive Advances in Cancer Treatment and Biomarker Discovery
Recent developments underscore a transformative era in oncology, where novel immunotherapies and artificial intelligence converge to enhance cancer patient outcomes. Bispecific antibodies...
Innovations in Imaging and Sensor Technologies Promise Enhanced Biomedical and Environmental Applications
Researchers are pioneering new sensor and imaging technologies with applications across medicine and environmental monitoring. A perovskite-based image sensor developed by ETH Zurich and Empa...
AI and Computational Methods Revolutionize Drug Discovery and Genome Editing
Artificial intelligence and computational strategies are reshaping biotechnology with accelerated drug design and editing technologies. Insilico Medicine’s Chemistry42 AI platform identified novel...
Environmental and Microbiome Research Uncovers Links to Human Health and Climate Challenges
Recent studies illuminate critical intersections between environmental factors, microbiomes, and human health. Research connects proximity to microplastic-contaminated oceans with elevated...
Biotech Financing and Industry Movements Shape Future Innovation Landscape
Recent months have witnessed vibrant financing activity and strategic movements within the biotech sector. Notably, Caris Life Sciences raised $494 million in a public offering to bolster its...
FDA Launches New Priority Review Voucher Program to Accelerate Drug Approval
The U.S. Food and Drug Administration (FDA) announced a pilot program introducing a priority review voucher to accelerate the approval process for drugs addressing national health priorities....
Lilly's $1.3 Billion Acquisition of Verve Therapeutics for Gene Editing in Cardiovascular Disease
Eli Lilly is set to acquire Verve Therapeutics for up to $1.3 billion, including milestone payments, to enhance its cardiovascular disease treatment portfolio with gene-editing therapies. Verve’s...
Advancements in Cancer Immunotherapy Biomarkers and Resistance Studies
Recent studies have unveiled novel insights into cancer immunotherapy resistance and predictive biomarker development. VIB-KU Leuven researchers revealed a paradoxical role of natural killer cells...
Breakthroughs in AI-Driven Protein Design and Drug Discovery Platforms
Artificial intelligence continues to reshape drug discovery with novel protein design platforms. The European Molecular Biology Laboratory introduced AlphaDesign, an AI-driven framework enabling...
Emerging Liver Cancer Therapies and Genomic Diagnostics in Pediatrics
Innovations in liver cancer treatment feature prominently with University of Hong Kong researchers securing global approvals for a dual immunotherapy combining nivolumab and ipilimumab to improve...
COVID-19 Vaccine Policy and Advisory Committee Shake-Up Sparks Controversy
Significant shifts in U.S. vaccine policymaking occurred following Health and Human Services Secretary Robert F. Kennedy Jr.'s dismissal of all 17 members of the CDC’s Advisory Committee on...
Precision Oncology and CAR-T Innovations in Solid Tumors
Calibr-Skaggs Institute initiated a first-in-human trial of a novel switchable CAR-T cell therapy for metastatic breast cancer, combining engineered autologous T cells with an antibody-based...
Innovations in Biopharmaceutical Marketing Amid Budget Constraints
A recent survey of European pharmaceutical marketers reveals increasing pressures from shrinking budgets, escalating targets, and stringent compliance demands. Marketers grapple with challenges...
New Gene and Epigenetic Discoveries in Autoimmune and Cancer Diseases
Cutting-edge research elucidates genetic and epigenetic contributors to systemic sclerosis (SSc) and cancers. Single-cell RNA sequencing has identified immune cell subtypes linking to disease...
Financial Flows and Challenges in Biotech Amid Turbulent Markets
The biotech sector faces an uncertain market outlook dominated by variables like tax policies, tariffs, and interest rates as key determinants of future growth. EY analysts underscore constrained...
FDA Accelerates Drug Review with New Voucher Program
The U.S. Food and Drug Administration has unveiled a pilot voucher program designed to expedite the review process for drugs that align with specified national health priorities. This initiative...